CN109260297B - A Chinese medicinal composition for treating hemorrhoid, and its preparation method - Google Patents
A Chinese medicinal composition for treating hemorrhoid, and its preparation method Download PDFInfo
- Publication number
- CN109260297B CN109260297B CN201811449144.XA CN201811449144A CN109260297B CN 109260297 B CN109260297 B CN 109260297B CN 201811449144 A CN201811449144 A CN 201811449144A CN 109260297 B CN109260297 B CN 109260297B
- Authority
- CN
- China
- Prior art keywords
- parts
- hemorrhoids
- traditional chinese
- chinese medicine
- raw materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000014617 hemorrhoid Diseases 0.000 title claims abstract description 52
- 239000000203 mixture Substances 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 239000003814 drug Substances 0.000 claims abstract description 84
- 239000002994 raw material Substances 0.000 claims abstract description 25
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000006187 pill Substances 0.000 claims abstract description 14
- 241000246044 Sophora flavescens Species 0.000 claims abstract description 13
- 241000218645 Cedrus Species 0.000 claims abstract description 12
- 235000001855 Portulaca oleracea Nutrition 0.000 claims abstract description 12
- 238000002791 soaking Methods 0.000 claims abstract description 12
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 11
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 11
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 11
- 240000008365 Celosia argentea Species 0.000 claims abstract description 11
- 235000000722 Celosia argentea Nutrition 0.000 claims abstract description 11
- 241000258920 Chilopoda Species 0.000 claims abstract description 11
- 244000035851 Chrysanthemum leucanthemum Species 0.000 claims abstract description 11
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims abstract description 11
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 11
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 11
- 239000004863 Frankincense Substances 0.000 claims abstract description 11
- 241000206469 Pulsatilla Species 0.000 claims abstract description 11
- 238000001914 filtration Methods 0.000 claims abstract description 11
- 244000062995 Cassia occidentalis Species 0.000 claims abstract description 10
- 235000001948 Cassia occidentalis Nutrition 0.000 claims abstract description 10
- 239000007788 liquid Substances 0.000 claims abstract description 9
- 238000001035 drying Methods 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 3
- 244000234609 Portulaca oleracea Species 0.000 claims abstract 2
- 240000001949 Taraxacum officinale Species 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims description 17
- 244000046101 Sophora japonica Species 0.000 claims description 8
- 235000010586 Sophora japonica Nutrition 0.000 claims description 8
- 230000000694 effects Effects 0.000 abstract description 54
- 239000008280 blood Substances 0.000 abstract description 13
- 210000004369 blood Anatomy 0.000 abstract description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 12
- 201000010099 disease Diseases 0.000 abstract description 11
- 239000003053 toxin Substances 0.000 abstract description 5
- 208000032177 Intestinal Polyps Diseases 0.000 abstract description 4
- 241000219784 Sophora Species 0.000 abstract description 4
- 208000001848 dysentery Diseases 0.000 abstract description 4
- 241000245665 Taraxacum Species 0.000 description 20
- 229940079593 drug Drugs 0.000 description 20
- 241000700159 Rattus Species 0.000 description 12
- 241000219304 Portulacaceae Species 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 241000721047 Danaus plexippus Species 0.000 description 7
- 230000035876 healing Effects 0.000 description 7
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 6
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 6
- 238000004140 cleaning Methods 0.000 description 6
- 230000000857 drug effect Effects 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 241000402754 Erythranthe moschata Species 0.000 description 5
- 102000004889 Interleukin-6 Human genes 0.000 description 5
- 108090001005 Interleukin-6 Proteins 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 229940100601 interleukin-6 Drugs 0.000 description 5
- 230000001678 irradiating effect Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 4
- 230000003467 diminishing effect Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 108090000193 Interleukin-1 beta Proteins 0.000 description 3
- 102000003777 Interleukin-1 beta Human genes 0.000 description 3
- 208000004680 Rectal Fistula Diseases 0.000 description 3
- 206010002156 anal fistula Diseases 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 2
- 229940116229 borneol Drugs 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000201986 Cassia tora Species 0.000 description 1
- 235000014552 Cassia tora Nutrition 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 101001033286 Mus musculus Interleukin-1 beta Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 101001076393 Rattus norvegicus Interleukin-1 beta Proteins 0.000 description 1
- 208000015815 Rectal disease Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000005415 artificial ingredient Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 201000007772 internal hemorrhoid Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000276 sedentary effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 235000021259 spicy food Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Insects & Arthropods (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention provides a traditional Chinese medicine composition for treating hemorrhoids, which is mainly prepared from the following raw materials: by mass, 0.1-1 part of Chinese pulsatilla root, 0.5-2 parts of feather cockscomb, 1-3 parts of cedar, 0.5-1.5 parts of wild chrysanthemum flower, 0.1-1 part of centipede, 1-3 parts of sophora twig, 0.5-2 parts of sophora flavescens, 0.5-1.5 parts of dandelion root, 0.5-1.5 parts of purslane, 0.5-1.5 parts of cassia occidentalis, 0.1-1 part of frankincense and 0.1-1 part of longan pulp. The preparation method comprises the following steps: mixing the raw materials, soaking for more than 5 hr, decocting in water for more than 4 hr, filtering the residue, collecting the medicinal liquid, concentrating into paste, drying, and making into pill. The traditional Chinese medicine composition for treating hemorrhoids provided by the embodiment of the invention has a good curative effect on hemorrhoids, also has the efficacy of treating diseases such as heat-toxin dysentery, intestinal polyps, blood heat and the like, and can not relapse after being cured.
Description
Technical Field
The invention relates to the field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition for treating hemorrhoids and a preparation method thereof.
Background
At present, social competition is increasingly violent, the living rhythm of people is accelerated, the mental stress is enhanced, and the environment is increasingly worsened, so that a plurality of people are always in a sub-health state, particularly office workers with high working pressure and irregular biological cycle. In view of the long-term sitting before computer in daily life, diseases related to lumbar vertebra, cervical vertebra or other parts can be brought. Hemorrhoids, whether internal or external, are more and more advanced in modern, especially young, patients, and in severe cases, other diseases may also be caused.
Hemorrhoids are common diseases in the anal region, and can occur at any age, but the incidence rate gradually increases with age. In China, hemorrhoids are the most common anorectal diseases, and the expressions of 'nine hemorrhoids for men' and 'ten hemorrhoids for women' are plain. The incidence of hemorrhoids is about 5% in the united states, and this difference may be related to the decision criteria.
At present, no effective treatment method or medicine exists in the prior art, and generally, the general method is to adopt medicines for control, wherein the medicines comprise suppository, ointment and lotion, most of which contain traditional Chinese medicine components, although the medicines have certain curative effect, the effect is not obvious, only the temporary relief effect can be realized, and the effect cannot be lasting. Moreover, the existing medicines on the market have the side effects of large self side effect, drug dependence, poor long-term curative effect, damage to organisms and the like, the traditional Chinese medicine composition has the side effects of large damage to other functions of human bodies while achieving the purpose of controlling the state of an illness, relapse and relapse of the patient once the patient stops taking the medicine, great pain is brought to the patient, the treatment process is long, and the effect is slow.
In view of the above, the present invention is particularly proposed.
Disclosure of Invention
The invention aims to provide a traditional Chinese medicine composition for treating hemorrhoids, which is simple to prepare, easily available in raw materials, natural in raw materials and free of any side effect on a human body, has a good curative effect on hemorrhoids, can be used for mainly treating internal hemorrhoids, external hemorrhoids, mixed hemorrhoids, anal fistula and other symptoms, can not relapse after healing, takes effect quickly, can achieve a healing effect after being used for 10 days as a treatment course, can achieve the healing effect after being generally used for 1-3 treatment courses, has a very remarkable effect, enables the human body to be healthier, has an effect of assisting in treating heat-toxin dysentery, intestinal polyp, blood heat and other symptoms, and also has a certain auxiliary curative effect on patients with high blood fat.
The second objective of the present invention is to provide a preparation method of the above traditional Chinese medicine composition for treating hemorrhoids, the preparation method has the advantages of completely retaining the effective ingredients of the medicine, and the method is simple and easy to operate, and has mild operation conditions.
In order to achieve the above purpose of the present invention, the following technical solutions are adopted:
the embodiment of the invention provides a traditional Chinese medicine composition for treating hemorrhoids, which is mainly prepared from the following raw materials: by mass, 0.1-1 part of Chinese pulsatilla root, 0.5-2 parts of feather cockscomb, 1-3 parts of cedar, 0.5-1.5 parts of wild chrysanthemum flower, 0.1-1 part of centipede, 1-3 parts of sophora twig, 0.5-2 parts of sophora flavescens, 0.5-1.5 parts of dandelion root, 0.5-1.5 parts of purslane, 0.5-1.5 parts of cassia occidentalis, 0.1-1 part of frankincense and 0.1-1 part of longan pulp.
In the prior art, the traditional Chinese medicines and the western medicines for treating the hemorrhoids are very many, but generally have the problems of slow effect, large side effect after treatment, easy relapse of the hemorrhoids and the like, and the effect of thorough cure cannot be achieved.
The invention aims to solve a plurality of technical problems in the prior art, provides a traditional Chinese medicine composition which can realize the thorough cure of hemorrhoids and achieve excellent treatment effect, and is invented by the inventor based on the traditional Chinese medicine theory and combined with early clinical experience.
The traditional Chinese medicine composition for treating hemorrhoids perfectly overcomes the technical problems in the prior art, has various dosage forms, convenient use and no toxic or side effect, can achieve the effect of treating hemorrhoids fundamentally, is mainly used for treating internal hemorrhoids, external hemorrhoids, mixed hemorrhoids, anal fistula and other symptoms, can not relapse after healing, has quick response, is a treatment course of 10 days, can achieve the healing effect after being generally used for 1 to 3 treatment courses, has very remarkable effect, makes human body more healthy and prolongs life, has the auxiliary treatment effects of heat-toxin dysentery, intestinal polyp, blood heat and other symptoms, and also has certain auxiliary curative effect on patients with high blood fat.
Preferably, as a further implementable scheme, by mass, 0.3-0.7 part of Chinese pulsatilla root, 0.6-1.5 parts of feather cockscomb, 1.5-2.5 parts of cedar, 0.8-1.2 parts of wild chrysanthemum flower, 0.3-0.8 part of centipede, 1.5-2.5 parts of sophora twig, 0.8-1.5 parts of sophora flavescens ait, 0.7-1.2 parts of dandelion root, 0.7-1.2 parts of purslane, 0.7-1.2 parts of cassia tora, 0.3-0.8 part of frankincense and 0.2-0.8 part of longan pulp.
Preferably, as a further implementable scheme, by mass, 0.5 parts of Chinese pulsatilla root, 1 part of feather cockscomb, 2 parts of cedar, 1 part of wild chrysanthemum flower, 0.5 part of centipede, 2 parts of sophora twig, 1 part of sophora flavescens, 1 part of dandelion root, 1 part of purslane, 1 part of cassia occidentalis, 0.5 part of frankincense and 0.5 part of longan pulp.
In the raw material medicinal materials of the invention, the principle of monarch, minister, assistant and guide is utilized, the sophora japonica branch, the dandelion root, the sophora flavescens ait, the cedar and the purslane are used as monarch medicaments to mainly play a role in treatment, wherein the dandelion root has the functions of removing heat, inducing diuresis, reducing swelling and resisting infection and also has a certain anti-tumor effect, the sophora flavescens ait has certain effects of removing heat toxin and resisting tumor, the cedar has the effects of stopping bleeding and diminishing inflammation, the purslane has the effects of diminishing inflammation, detoxifying, reducing blood fat and relieving pain, the sophora japonica branch has the effects of dissipating blood stasis and stopping bleeding, the 5 monarch medicaments are matched to achieve the effects of relieving pain and reducing swelling on the surface, but completely eliminate the affected part of a patient with hemorrhoids, find the diseased root accurately, deeply remove the diseased part fundamentally and really realize the effect of removing the diseases, and the 5 monarch medicaments have mutual effects, the ideal effect of eliminating the diseases can be achieved only by matching the medicines, and the medicine effect is greatly reduced by lacking any one of the medicines.
It can be seen that after the 5 medicines are compounded, the treatment is on one hand, and on the other hand, the efficacy is obviously enhanced after the compatibility of medicines, and the effect of inhibiting recurrence is also achieved to a certain extent, as is known, the most of the hemorrhoids occur because of sedentary and motionless conditions and are always loved to eating spicy foods, but after the medicine treatment of the invention and the treatment of common hemorrhoids on the market, the morbidity of the former can be controlled below 10 percent, and the morbidity of the latter reaches more than 50 percent, so that the treatment effect of the traditional Chinese medicine formula of the invention is very excellent, and the traditional Chinese medicine formula in the prior art is not recorded at all and belongs to a technical blank point.
In the above-mentioned prescription, it should be noted that the dandelion must be selected to the dandelion root when the dandelion goes into medicine, rather than the dandelion leaf, the drug effect of dandelion root itself will be more strong some, and difficult shaping during follow-up preparation of dandelion leaf, the drug effect is not easily extracted like the dandelion root, so according to the discovery of a large amount of practices of inventor, the curative effect of dandelion root all will be superior to the dandelion leaf, only adopt the dandelion root to go into medicine after, just can form good compatibility of medicines relation.
The traditional Chinese medicine formula mainly comprises 12 medicinal materials, and other components except the monarch drug in the 5 medicinal materials are ministerial drugs and mainly play an auxiliary curative effect. In ministerial drugs, the Chinese pulsatilla root has the effects of resisting bacteria, diminishing inflammation and cooling blood, the feather cockscomb has the effects of stopping bleeding, diminishing swelling, detoxifying and protecting liver, the wild chrysanthemum has the effects of dispelling stasis and cold, improving immunity and accelerating wound recovery, the centipede has the effects of detoxifying and counteracting toxic substances, the cassia occidentalis has the effects of reducing blood pressure, reducing blood fat and removing liver toxin, the frankincense has the effects of dispelling wind and removing blood stasis, relieving pain and promoting tissue regeneration, and the longan pulp has the effects of enriching blood and dispelling cold.
Although a plurality of traditional Chinese medicine hemorrhoid medicines exist in the prior art, the hemorrhoid medicines are generally externally applied medicines, the operation is not convenient, the treatment effect is common, the externally applied medicines are generally safflower, musk and camphor, some borneol can be added for good patient sensitivity, the hemorrhoid medicines have high toxicity and large side effect, the borneol only has the effect of temporary relief and cannot be eradicated, and the musk has large toxicity, so the raw material medicines adopted in the past are abandoned when the medicine is used as the medicine ingredients.
The traditional Chinese medicine is an oral medicine, is prepared into pills for direct oral administration, is very convenient, reduces the pain of patients, is more scientific in matching dosage, and achieves good treatment effect after mutual compatibility.
In the prior art, some oral traditional Chinese medicine preparations for treating hemorrhoids are available, but some sugar is added in order to cover the taste of the traditional Chinese medicine, and some medicinal materials which are nourishing and helpful for defecation are also selected for assistance, but the ingredients are not symptomatic, and the medicinal effect is influenced to a certain extent after some sugar is added.
The embodiment of the invention provides a formula of the traditional Chinese medicine composition, and also provides a preparation method of the traditional Chinese medicine composition, which comprises the following steps:
mixing the raw materials, soaking for more than 5 hr, decocting in water for more than 4 hr, filtering the residue, collecting the medicinal liquid, concentrating into paste, drying, and making into pill.
Preferably, the soaking time is controlled to be 7-8 h.
Preferably, the amount of water added in the step of decocting with water is 20-30 times of the mass of all the raw materials.
Preferably, the steps of sequentially adding water for decoction, filtering the residues and collecting the liquid medicine are repeated back and forth for 10-15 times, and the time for each decoction is controlled to be 4-5 h.
Preferably, the paste is concentrated to 60 ℃ and has a relative density of 1.1-2, and the relative density is preferably controlled to be 1.12-1.5.
The preparation method is simple in operation, no waste residue is generated in the operation process, in addition, all the traditional Chinese medicine raw materials are preferably subjected to pretreatment operations such as picking, cleaning, irradiation and the like, and then subsequent soaking is carried out, the irradiation can achieve the effects of killing microorganisms, preventing corrosion and sterilizing, the irradiation temperature is not too high, the temperature is generally controlled to be 50-60 ℃, and the effective components in the raw materials can be damaged due to too high temperature.
The preparation method fully extracts the drug effect through a decoction and concentration mode, belongs to a preferred method relative to the exertion of the drug effect, and aims to fully integrate the drug effect of each medicinal material in the raw materials into a concentrated solution, the medicinal materials must be soaked for a period of time before decoction, the soaking time is more than 5 hours, preferably 7-8 hours, then the medicinal materials are decocted by adding water, the water addition amount is generally 20-30 times of the total mass of all the raw materials, too much or too little is not beneficial to the exertion of the drug effect, and the water addition decocting time is controlled to be more than 4 hours.
In order to fully extract the effective components in the medicinal materials, the steps of sequentially adding water for decoction, filtering residues and collecting liquid medicine are preferably repeated for 10-15 times, and the time for each decoction is controlled to be 4-5h, so that the medicine residues can be fully utilized after repeated decoction.
During concentration, the concentrated solution is concentrated into thick paste with the relative density controlled between 1.1 and 2 (60 ℃), the relative density range is more favorable for human body absorption, and the relative density is more preferably controlled between 1.12 and 1.5.
The preparation process of the invention achieves absolutely pure nature, does not use modern complex processing technology, reserves the traditional preparation mode, and simultaneously does not add any artificial ingredients so as to reserve the optimal effect of the product formula.
Detailed Description
Embodiments of the present invention will be described in detail below with reference to examples, but it will be understood by those skilled in the art that the following examples are only illustrative of the present invention and should not be construed as limiting the scope of the present invention. The examples, in which specific conditions are not specified, were conducted under conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used are not indicated by the manufacturer, and are all conventional products available commercially.
Example 1
The preparation method of the traditional Chinese medicine composition for treating the hemorrhoids comprises the following steps:
1) weighing the following raw materials by mass: 0.1kg of Chinese pulsatilla root, 2kg of feather cockscomb, 1kg of cedar, 1.5kg of wild chrysanthemum flower, 0.1kg of centipede, 3kg of sophora japonica branch, 0.5kg of sophora flavescens, 1.5kg of dandelion root, 0.5kg of purslane, 1.5kg of cassia occidentalis, 0.1kg of frankincense and 1kg of longan pulp;
2) selecting the above raw materials, cleaning, irradiating, soaking for 5 hr, decocting with 20 times of water for 4 hr, filtering the residue, collecting the filtrate, concentrating, drying, and making into pill (1 g per pill).
Example 2
The preparation method of the traditional Chinese medicine composition for treating the hemorrhoids comprises the following steps:
1) weighing the following raw materials by mass: 1kg of Chinese pulsatilla root, 0.5kg of feather cockscomb, 3kg of cedar, 0.5kg of wild chrysanthemum flower, 1kg of centipede, 1kg of sophora japonica branch, 2kg of sophora flavescens, 0.5kg of dandelion root, 1.5kg of purslane, 0.5kg of cassia occidentalis, 1kg of frankincense and 0.1kg of longan pulp;
2) selecting the above materials, cleaning, irradiating, soaking for 7 hr, decocting with 30 times of water for 5 hr, filtering the residue, collecting the medicinal liquid, concentrating to relative density of 1.1-2 (60 deg.C), drying, and making into pill (1 g per pill).
Example 3
The preparation method of the traditional Chinese medicine composition for treating the hemorrhoids comprises the following steps:
1) weighing the following raw materials by mass: 0.3kg of Chinese pulsatilla root, 1.5kg of feather cockscomb, 1.5kg of cedar, 1.2kg of wild chrysanthemum flower, 0.3kg of centipede, 2.5kg of sophora japonica branch, 0.8kg of sophora flavescens, 1.2kg of dandelion root, 0.7kg of purslane, 1.2kg of cassia occidentalis, 0.3kg of frankincense and 0.8kg of longan pulp;
2) selecting the above raw materials, cleaning, irradiating, soaking for 6 hr, adding 25 times of water, decocting for 8 hr, filtering the residue, collecting the medicinal liquid, concentrating to relative density of 1.12-1.5 (60 deg.C), drying, and making into pill (1 g per pill).
Example 4
The preparation method of the traditional Chinese medicine composition for treating the hemorrhoids comprises the following steps:
1) weighing the following raw materials by mass: 0.7kg of Chinese pulsatilla root, 0.6kg of feather cockscomb, 2.5kg of cedar, 0.8kg of wild chrysanthemum flower, 0.8kg of centipede, 1.5kg of sophora japonica branch, 1.5kg of sophora flavescens, 0.7kg of dandelion root, 1.2kg of purslane, 0.7kg of cassia occidentalis, 0.8kg of frankincense and 0.2kg of longan pulp;
2) selecting the above raw materials, cleaning, irradiating, soaking for 6 hr, adding 25 times of water, decocting for 8 hr, filtering the residue, collecting the medicinal liquid, concentrating to relative density of 1.12-1.5 (60 deg.C), drying, and making into pill (1 g per pill).
Example 5
The preparation method of the traditional Chinese medicine composition for treating the hemorrhoids comprises the following steps:
1) weighing the following raw materials by mass: 0.5kg of Chinese pulsatilla root, 1kg of feather cockscomb, 2kg of cedar, 1kg of wild chrysanthemum flower, 0.5kg of centipede, 2kg of sophora japonica branch, 1kg of sophora flavescens, 1kg of dandelion root, 1kg of purslane, 1kg of cassia occidentalis, 0.5kg of frankincense and 0.5kg of longan pulp;
2) selecting the above raw materials, cleaning, irradiating, soaking for 6 hr, adding 27 times of water, decocting for 8 hr, filtering the residue, collecting the medicinal liquid, concentrating to relative density of 1.12-1.5 (60 deg.C), drying, and making into pill (1 g per pill).
Experimental example 1
1. Test materials
1.1 animal SPF SD rats, 180-200 g, 60 animals, half male and half female; SPF-grade KM mice, which are half male and female, 22-25 g, 60 mice, and have the qualification number of SCXK (Lu) 2014-0007; provided by the company Jinanpunyue laboratory animal Breeding Co., Ltd, the laboratory animal uses license number SYXK (Yu) 2015-. The experiment meets the experimental animal theory standard of the Chinese medicine university in Henan.
1.2 medicine and reagent Mayilong musk haemorrhoids ointment (manufactured by Mayilong pharmaceutical industry group Limited company, batch No. 170209); acetic acid (Beijing chemical plant, batch number 160805); rat interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha); mouse IL-1 beta, TNF-alpha ELISA kit (Shanghai preferred Biotech Co., Ltd., batch No. E20170801A).
1.3 method take 60 rats, after 3 days of adaptive feeding, randomly take 10 rats as blank group, other animals firstly disinfect perianal skin, 0.05mL of 75% acetic acid solution is injected into perianal subcutaneous skin of the rats, after 24 hours of observation, the rats with white ulcer surface, perianal swelling and inflammatory exudation are observed to indicate that the model is successfully made, the rats successfully made are randomly divided into 5 groups, each group comprises 10 rats, the first group is a model group, the second group is the traditional Chinese medicine composition of the embodiment 3 of the invention, the third group is the traditional Chinese medicine composition of the embodiment 4 of the invention, the fourth group is the traditional Chinese medicine composition of the embodiment 5, only the sophora flavescens are not added in the formula, the fifth group is a musk horse-responsive hemorrhoid ointment group, the dosage of each group is 5g/kg per day, the second group to the fourth group are taken once in the morning and evening respectively, the fifth group is smeared with musk hemorrhoid ointment of horse-responsive dragon, the application is divided into 3 smears for 10 min/time, the perianal area of the model group and the blank group is coated with normal saline by 3 times and 10 min/time for continuous treatment for 20 days.
1.4 test results
In the table below, TNF-alpha, IL-1 beta and IL-6 are all important inflammatory factors, and after 20 days of treatment, the anti-inflammatory factor condition in rat serum is detected, and the index of the anti-inflammatory factor condition can indicate the degree of tissue inflammation and tissue injury.
TABLE 1 test results
| Group of | Number of rats | TNF-α | IL-1β | IL-6 |
| Blank group | 10 pieces of | 397.42±34.45 | 101.23±14.34 | 301.54±50.12 |
| First group | 10 pieces of | 445.17±35.27 | 139.18±15.17 | 391.23±65.27 |
| Second group | 10 pieces of | 404.23±36.56 | 107.21±15.88 | 309.21±40.26 |
| Third group | 10 pieces of | 405.13±37.21 | 106.91±14.98 | 310.34±45.32 |
| Fourth group | 10 pieces of | 432.23±35.01 | 129.99±15.09 | 376.09±47.89 |
| Fifth group | 10 pieces of | 433.01±34.98 | 130.01±14.29 | 379.47±41.36 |
From the results in table 1 above, the levels of the indexes of the model group in the first group are significantly increased (P <0.01) compared with the blank group, the levels of TNF-alpha, IL-1 beta and IL-6 in rat model hemorrhoids (P <0.01) in the second group and the third group are significantly reduced compared with the model group, the treatment condition of the fourth group and the fifth group is not significant compared with the model group, from the above test results, it can be found that the traditional Chinese medicine composition of the invention has good treatment effect on the mouse model hemorrhoids, but each added medicine is essential, especially plays a key role as a monarch medicine, the medicine efficacy of the whole prescription is greatly influenced after the medicine primer component is lacked, which is equivalent to the great discount of the medicine efficacy of the whole prescription, and the test results of other monarch medicines are similar to the above results if any one medicine is reduced, in addition, other components of the traditional Chinese medicine composition may influence the efficacy to some extent, but the influence degree is not particularly large compared with the most important 5 medicines.
Experimental example 2
After 20 days of treatment by the method of the experimental example 1, the medicine is thoroughly removed, the perianal area is cleaned, and the perianal area is scored and scored, wherein the score is 0, the healing is complete, the score is 1, the healing is basically performed, the score is 2, the score is a little ulcer exudate, and the score is 3, and the details are shown in the following table 1.
TABLE 2 scoring results
| Group of | Number of rats | 0 point (min) | 1 minute (1) | 2 is divided into | 3 points of |
| Blank group | 10 pieces of | 12 | 0 | 0 | 0 |
| First group | 10 pieces of | 0 | 0 | 2 | 10 |
| Second group | 10 pieces of | 11 | 1 | 0 | 0 |
| Third group | 10 pieces of | 12 | 0 | 0 | 0 |
| Fourth group | 10 pieces of | 0 | 0 | 10 | 2 |
| Fifth group | 10 pieces of | 0 | 0 | 9 | 3 |
From the scoring results in the table above, it can be seen that the traditional Chinese medicine composition of the present invention has a very excellent therapeutic effect, and after a period of treatment, a small amount of acetic acid solution is injected to the periphery of the rat, each dosage is very small, and the continuous injection lasts for about 10 days, so that it can be found that the perianal swelling does not occur in the second group and the third group, but the perianal swelling occurs in the rats of the fourth group and the fifth group after about 5 days.
Case 1
After a certain Wang 72 years old, a male, a driver and internal hemorrhoids recur for 10 years after two operations, the formula of the embodiment 5 of the invention is taken, and the using method is as follows: the medicine is taken 6 granules in an early stage with an empty stomach, once a day, 10 days as a treatment course, and the medicine is cured in two treatment courses until the disease is not relapsed.
Case 2
When a certain amount of plum, a large book of a team, 54 years old, suffers from heart disease, hypertension, diabetes and external hemorrhoid for 5 years, the formula of the embodiment 5 of the invention is taken, and the using method is as follows: the medicine is taken 6 granules in an early stage with an empty stomach, once a day, 10 days as a treatment course, and the disease is cured in one treatment course, so far, the disease does not relapse.
Case 3
When a certain person opens, a officer and anal fistula cannot move and repeated pain is hard to endure, the formula of the embodiment 4 of the invention is taken, and the using method is as follows: the medicine is taken 6 granules in an early stage with an empty stomach, once a day, 10 days as a treatment course, and the medicine is cured in three treatment courses until the disease is not relapsed.
Case 4
After a certain grandson, office clerks accompanied by hyperlipidemia for many years take the formula of the embodiment 3 of the invention, and the use method is as follows: the preparation is taken once a day with 6 granules in an empty stomach, 10 days as a treatment course, and three treatment courses, and the blood fat is recovered to a normal level.
Case 5
Wu Yi in Wu, prepared for pregnancy but suffering from mixed hemorrhoids for years and accompanied with hypertension, takes the formula of the invention in the embodiment 4, and the using method is as follows: taking 6 granules in the morning on an empty stomach, once a day, 10 days as a treatment course, two treatment courses, completely curing, maintaining the blood pressure at a normal level all the time during pregnancy, and finally giving birth normally.
The traditional Chinese medicine composition disclosed by the embodiment of the invention has a very good treatment effect on internal hemorrhoid, external hemorrhoid, mixed hemorrhoid and other hemorrhoid diseases, and has certain auxiliary effects on toxic-heat dysentery, intestinal polyp, blood heat, hyperlipidemia and other diseases through daily practice.
While particular embodiments of the present invention have been illustrated and described, it would be obvious that various other changes and modifications can be made without departing from the spirit and scope of the invention. It is therefore intended to cover in the appended claims all such changes and modifications that are within the scope of this invention.
Claims (7)
1. A traditional Chinese medicine composition for treating hemorrhoids is characterized by being prepared from the following raw materials: the traditional Chinese medicine composition comprises, by mass, 0.5 part of Chinese pulsatilla root, 1 part of feather cockscomb, 2 parts of cedar, 1 part of wild chrysanthemum flower, 0.5 part of centipede, 2 parts of sophora japonica branch, 1 part of sophora flavescens, 1 part of dandelion root, 1 part of purslane, 1 part of cassia occidentalis, 0.5 part of frankincense and 0.5 part of longan pulp.
2. The method for preparing a Chinese medicinal composition for treating hemorrhoids as claimed in claim 1, comprising the steps of:
mixing the raw materials, soaking for more than 5 hr, decocting in water for more than 4 hr, filtering the residue, collecting the medicinal liquid, concentrating into paste, drying, and making into pill.
3. The method of claim 2, wherein the soaking time is controlled to 7-8 hours.
4. The preparation method according to claim 2, wherein the amount of water added in the step of decocting with water is 20-30 times of the mass of all the raw materials.
5. The method of claim 2, wherein the steps of decocting with water, filtering the residue, and collecting the decoction are repeated for 10-15 times, and the time for each decoction is controlled to be 4-5 h.
6. The method of claim 2, wherein the concentration is performed to form a paste having a relative density of 1.1 to 2 at 60 ℃.
7. The method of claim 6, wherein the relative density is controlled to be 1.12 to 1.5.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811449144.XA CN109260297B (en) | 2018-11-28 | 2018-11-28 | A Chinese medicinal composition for treating hemorrhoid, and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811449144.XA CN109260297B (en) | 2018-11-28 | 2018-11-28 | A Chinese medicinal composition for treating hemorrhoid, and its preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN109260297A CN109260297A (en) | 2019-01-25 |
| CN109260297B true CN109260297B (en) | 2021-07-06 |
Family
ID=65187169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811449144.XA Active CN109260297B (en) | 2018-11-28 | 2018-11-28 | A Chinese medicinal composition for treating hemorrhoid, and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109260297B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104706769A (en) * | 2013-12-13 | 2015-06-17 | 淄博开发区亚大制药有限责任公司 | Hemorrhoid treating traditional Chinese medicine and use method thereof |
-
2018
- 2018-11-28 CN CN201811449144.XA patent/CN109260297B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104706769A (en) * | 2013-12-13 | 2015-06-17 | 淄博开发区亚大制药有限责任公司 | Hemorrhoid treating traditional Chinese medicine and use method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN109260297A (en) | 2019-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ragazzi | Amber, a stone of sun for ancient medicines | |
| CN109260297B (en) | A Chinese medicinal composition for treating hemorrhoid, and its preparation method | |
| CN105963527A (en) | Traditional Chinese medicine extracting solution capable of quickly healing wound and preparation method thereof | |
| CN102139029B (en) | External Chinese medicinal preparation for treating trauma and preparation method thereof | |
| CN104069355A (en) | Medicinal composition for treating rheumatic arthritis and rheumatoid arthritis | |
| CN107050060A (en) | Treat psoriasic externally applied drug and pharmaceutical composition | |
| CN101480412A (en) | Honeybee four-treasure for treating prostatosis | |
| CN106822386A (en) | It is a kind of to treat bleeding gums, the oral care composition of gum pain | |
| CN1283391A (en) | Extracted liquor for disinfection | |
| KR101093006B1 (en) | Method for producing functional health food containing bezoar bovis used microbes and the functional health food produced by the same | |
| Afreen et al. | Therapeutic uses of earthworm–a review | |
| CN108567868A (en) | A kind of routed more external medicine composition and preparation method thereof of skin care | |
| CN115006466B (en) | Traditional Chinese medicine preparation for treating eczema with damp-heat and yang deficiency and preparation method thereof | |
| CN106924578A (en) | A kind of Chinese medicine for treating carbuncle furuncle poison | |
| CN116115687B (en) | Traditional Chinese medicine composition for gout and preparation method and application thereof | |
| CN103830679B (en) | A kind of medicine and application thereof for the treatment of irritable bowel syndrome | |
| CN102836306A (en) | Chinese medicine combination for treating horse traumatic injuries and preparation method of same | |
| CN113332365B (en) | Compound lithospermum ointment and preparation method thereof | |
| CN110025685B (en) | A liquid preparation containing propolis composition | |
| CN102462785A (en) | Medicinal composition for treating acquired immune deficiency syndrome viruses and preparation method thereof | |
| CN118634276A (en) | Composition for treating or/and improving inflammatory bowel disease | |
| CN105055703A (en) | Anti-allergic traditional Chinese medicine composition and preparation method thereof | |
| CN105031164A (en) | Internal medicine capable of treating tetanus and preparation method of internal medicine | |
| CN116370565A (en) | Medical biogel for treating hemorrhoids and preparation method thereof | |
| CN104623291A (en) | Traditional Chinese medicine for treating peptic ulcer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |